Loading…
Bleomycin-Induced Fibrosis and the Effectiveness of Centella Asiatica as a Treatment
Plant treatment has been used for thousands of years and has been proven to treat acute and chronic diseases. The function of the traditional plant is as an antimicrobial agent, anticancer, antioxidant, and therapeutic gene in healing wounds and inflammation. Lung fibrosis caused by bleomycin can de...
Saved in:
Published in: | Journal of experimental pharmacology 2024-09, Vol.16, p.311-320 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c3129-17df2f7216c66cd75c47354365fd4927e2eaa875d515dda35b8e55be8585448a3 |
container_end_page | 320 |
container_issue | |
container_start_page | 311 |
container_title | Journal of experimental pharmacology |
container_volume | 16 |
creator | Soeroso, Noni Novisari Ichwan, Muhammad Wahyuni, Arlinda Sari Mariedina, Causa Trisna Pakpahan, Yabestin Alfrianus |
description | Plant treatment has been used for thousands of years and has been proven to treat acute and chronic diseases. The function of the traditional plant
is as an antimicrobial agent, anticancer, antioxidant, and therapeutic gene in healing wounds and inflammation. Lung fibrosis caused by bleomycin can develop into chronic lung disease, which ends in tissue death if not treated immediately. The purpose of this study is to predict and explain the impact of
extract on model rats exposed to bleomycin in their lungs as a treatment or anti-fibrinolysis.
This research is an analytical study with a randomized in-vivo experimental design divided into 3 groups of 5 male Wistar rats aged 10 weeks. Negative control group (K) with intratracheal induction of bleomycin alone. The positive group was given intratracheal bleomycin 4 mg/kg/BB on days 0 and 21 and added
induction at 400 mg (P1) on days 15 to 49. The other positive group was given intratracheal bleomycin 4 mg/kg/BB on days 0 and 21 and added
induction at 800 mg (P2) on days 15 to 49. Data were collected according to findings of lung histology analysis of rat samples.
In the interalveolar septum group, there was a difference in Masson's Trichrome staining results in groups K and P1 with p0.05).
The induction of bleomycin 4 mg/kg/BB was proven to cause fibrosis in the lungs of rats, and
extract was used as a treatment. Therefore, further research regarding antifibrotic drugs is hoped to reduce fibrotic areas significantly. |
doi_str_mv | 10.2147/JEP.S463899 |
format | article |
fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_71ddcfc62ffe42ba82353a678da9ab4e</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A815289565</galeid><doaj_id>oai_doaj_org_article_71ddcfc62ffe42ba82353a678da9ab4e</doaj_id><sourcerecordid>A815289565</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3129-17df2f7216c66cd75c47354365fd4927e2eaa875d515dda35b8e55be8585448a3</originalsourceid><addsrcrecordid>eNptkt-LEzEQxxdRvOO8J99lQRBBWptfm-RJaulp5UDB-hxmk0mbYzc5N9uD--9NbT1aMHlImHzmy8zkW1WvyWxKCZcfvy1_TH_yhimtn1WXhEg9IVzw5yf3i-o657tZWUxrKfjL6oJpxoXU-rJaf-4w9Y82xMkqup1FV9-Edkg55Bqiq8ct1kvv0Y7hASPmXCdfLzCO2HVQz3OAMVioodD1ekAY-_L2qnrhoct4fTyvql83y_Xi6-T2-5fVYn47sYzQUpx0nnpJSWObxjopLJdMcNYI77imEikCKCmcIMI5YKJVKESLSijBuQJ2Va0Oui7BnbkfQg_Do0kQzN9AGjYGhlJfh0YS56y3DS29cNqCokwwaKRyoKHlWLQ-HbTud22PzpY2BujORM9fYtiaTXowhHCmuNBF4f1RYUi_d5hH04ds93OKmHbZMEIInQmqRUHfHtANlNpC9KlI2j1u5ooIqrRo9tT0P1TZDvtgU0QfSvws4d1JwhahG7c5dbsxpJjPwQ8H0JafzgP6pz7JzOx9ZYqvzNFXhX5zOpon9p-L2B9yuMYn</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3111205295</pqid></control><display><type>article</type><title>Bleomycin-Induced Fibrosis and the Effectiveness of Centella Asiatica as a Treatment</title><source>Taylor & Francis Open Access</source><source>Publicly Available Content (ProQuest)</source><source>PubMed Central</source><creator>Soeroso, Noni Novisari ; Ichwan, Muhammad ; Wahyuni, Arlinda Sari ; Mariedina, Causa Trisna ; Pakpahan, Yabestin Alfrianus</creator><creatorcontrib>Soeroso, Noni Novisari ; Ichwan, Muhammad ; Wahyuni, Arlinda Sari ; Mariedina, Causa Trisna ; Pakpahan, Yabestin Alfrianus</creatorcontrib><description>Plant treatment has been used for thousands of years and has been proven to treat acute and chronic diseases. The function of the traditional plant
is as an antimicrobial agent, anticancer, antioxidant, and therapeutic gene in healing wounds and inflammation. Lung fibrosis caused by bleomycin can develop into chronic lung disease, which ends in tissue death if not treated immediately. The purpose of this study is to predict and explain the impact of
extract on model rats exposed to bleomycin in their lungs as a treatment or anti-fibrinolysis.
This research is an analytical study with a randomized in-vivo experimental design divided into 3 groups of 5 male Wistar rats aged 10 weeks. Negative control group (K) with intratracheal induction of bleomycin alone. The positive group was given intratracheal bleomycin 4 mg/kg/BB on days 0 and 21 and added
induction at 400 mg (P1) on days 15 to 49. The other positive group was given intratracheal bleomycin 4 mg/kg/BB on days 0 and 21 and added
induction at 800 mg (P2) on days 15 to 49. Data were collected according to findings of lung histology analysis of rat samples.
In the interalveolar septum group, there was a difference in Masson's Trichrome staining results in groups K and P1 with p<0.05 (p=0.036). However, there was no difference in histopathological staining results in groups K and P2 (p>0.05).
The induction of bleomycin 4 mg/kg/BB was proven to cause fibrosis in the lungs of rats, and
extract was used as a treatment. Therefore, further research regarding antifibrotic drugs is hoped to reduce fibrotic areas significantly.</description><identifier>ISSN: 1179-1454</identifier><identifier>EISSN: 1179-1454</identifier><identifier>DOI: 10.2147/JEP.S463899</identifier><identifier>PMID: 39345799</identifier><language>eng</language><publisher>New Zealand: Dove Medical Press Limited</publisher><subject>Bleomycin ; Cancer ; Care and treatment ; centella asiatica ; Chronic diseases ; Development and progression ; Fibrosis ; Lung diseases ; Original Research ; pulmonary fibrosis ; treatment</subject><ispartof>Journal of experimental pharmacology, 2024-09, Vol.16, p.311-320</ispartof><rights>2024 Soeroso et al.</rights><rights>COPYRIGHT 2024 Dove Medical Press Limited</rights><rights>2024 Soeroso et al. 2024 Soeroso et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3129-17df2f7216c66cd75c47354365fd4927e2eaa875d515dda35b8e55be8585448a3</cites><orcidid>0000-0002-2687-4924</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11438459/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11438459/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,36992,53770,53772</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39345799$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Soeroso, Noni Novisari</creatorcontrib><creatorcontrib>Ichwan, Muhammad</creatorcontrib><creatorcontrib>Wahyuni, Arlinda Sari</creatorcontrib><creatorcontrib>Mariedina, Causa Trisna</creatorcontrib><creatorcontrib>Pakpahan, Yabestin Alfrianus</creatorcontrib><title>Bleomycin-Induced Fibrosis and the Effectiveness of Centella Asiatica as a Treatment</title><title>Journal of experimental pharmacology</title><addtitle>J Exp Pharmacol</addtitle><description>Plant treatment has been used for thousands of years and has been proven to treat acute and chronic diseases. The function of the traditional plant
is as an antimicrobial agent, anticancer, antioxidant, and therapeutic gene in healing wounds and inflammation. Lung fibrosis caused by bleomycin can develop into chronic lung disease, which ends in tissue death if not treated immediately. The purpose of this study is to predict and explain the impact of
extract on model rats exposed to bleomycin in their lungs as a treatment or anti-fibrinolysis.
This research is an analytical study with a randomized in-vivo experimental design divided into 3 groups of 5 male Wistar rats aged 10 weeks. Negative control group (K) with intratracheal induction of bleomycin alone. The positive group was given intratracheal bleomycin 4 mg/kg/BB on days 0 and 21 and added
induction at 400 mg (P1) on days 15 to 49. The other positive group was given intratracheal bleomycin 4 mg/kg/BB on days 0 and 21 and added
induction at 800 mg (P2) on days 15 to 49. Data were collected according to findings of lung histology analysis of rat samples.
In the interalveolar septum group, there was a difference in Masson's Trichrome staining results in groups K and P1 with p<0.05 (p=0.036). However, there was no difference in histopathological staining results in groups K and P2 (p>0.05).
The induction of bleomycin 4 mg/kg/BB was proven to cause fibrosis in the lungs of rats, and
extract was used as a treatment. Therefore, further research regarding antifibrotic drugs is hoped to reduce fibrotic areas significantly.</description><subject>Bleomycin</subject><subject>Cancer</subject><subject>Care and treatment</subject><subject>centella asiatica</subject><subject>Chronic diseases</subject><subject>Development and progression</subject><subject>Fibrosis</subject><subject>Lung diseases</subject><subject>Original Research</subject><subject>pulmonary fibrosis</subject><subject>treatment</subject><issn>1179-1454</issn><issn>1179-1454</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNptkt-LEzEQxxdRvOO8J99lQRBBWptfm-RJaulp5UDB-hxmk0mbYzc5N9uD--9NbT1aMHlImHzmy8zkW1WvyWxKCZcfvy1_TH_yhimtn1WXhEg9IVzw5yf3i-o657tZWUxrKfjL6oJpxoXU-rJaf-4w9Y82xMkqup1FV9-Edkg55Bqiq8ct1kvv0Y7hASPmXCdfLzCO2HVQz3OAMVioodD1ekAY-_L2qnrhoct4fTyvql83y_Xi6-T2-5fVYn47sYzQUpx0nnpJSWObxjopLJdMcNYI77imEikCKCmcIMI5YKJVKESLSijBuQJ2Va0Oui7BnbkfQg_Do0kQzN9AGjYGhlJfh0YS56y3DS29cNqCokwwaKRyoKHlWLQ-HbTud22PzpY2BujORM9fYtiaTXowhHCmuNBF4f1RYUi_d5hH04ds93OKmHbZMEIInQmqRUHfHtANlNpC9KlI2j1u5ooIqrRo9tT0P1TZDvtgU0QfSvws4d1JwhahG7c5dbsxpJjPwQ8H0JafzgP6pz7JzOx9ZYqvzNFXhX5zOpon9p-L2B9yuMYn</recordid><startdate>20240930</startdate><enddate>20240930</enddate><creator>Soeroso, Noni Novisari</creator><creator>Ichwan, Muhammad</creator><creator>Wahyuni, Arlinda Sari</creator><creator>Mariedina, Causa Trisna</creator><creator>Pakpahan, Yabestin Alfrianus</creator><general>Dove Medical Press Limited</general><general>Dove</general><general>Dove Medical Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-2687-4924</orcidid></search><sort><creationdate>20240930</creationdate><title>Bleomycin-Induced Fibrosis and the Effectiveness of Centella Asiatica as a Treatment</title><author>Soeroso, Noni Novisari ; Ichwan, Muhammad ; Wahyuni, Arlinda Sari ; Mariedina, Causa Trisna ; Pakpahan, Yabestin Alfrianus</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3129-17df2f7216c66cd75c47354365fd4927e2eaa875d515dda35b8e55be8585448a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Bleomycin</topic><topic>Cancer</topic><topic>Care and treatment</topic><topic>centella asiatica</topic><topic>Chronic diseases</topic><topic>Development and progression</topic><topic>Fibrosis</topic><topic>Lung diseases</topic><topic>Original Research</topic><topic>pulmonary fibrosis</topic><topic>treatment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Soeroso, Noni Novisari</creatorcontrib><creatorcontrib>Ichwan, Muhammad</creatorcontrib><creatorcontrib>Wahyuni, Arlinda Sari</creatorcontrib><creatorcontrib>Mariedina, Causa Trisna</creatorcontrib><creatorcontrib>Pakpahan, Yabestin Alfrianus</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Journal of experimental pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Soeroso, Noni Novisari</au><au>Ichwan, Muhammad</au><au>Wahyuni, Arlinda Sari</au><au>Mariedina, Causa Trisna</au><au>Pakpahan, Yabestin Alfrianus</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bleomycin-Induced Fibrosis and the Effectiveness of Centella Asiatica as a Treatment</atitle><jtitle>Journal of experimental pharmacology</jtitle><addtitle>J Exp Pharmacol</addtitle><date>2024-09-30</date><risdate>2024</risdate><volume>16</volume><spage>311</spage><epage>320</epage><pages>311-320</pages><issn>1179-1454</issn><eissn>1179-1454</eissn><abstract>Plant treatment has been used for thousands of years and has been proven to treat acute and chronic diseases. The function of the traditional plant
is as an antimicrobial agent, anticancer, antioxidant, and therapeutic gene in healing wounds and inflammation. Lung fibrosis caused by bleomycin can develop into chronic lung disease, which ends in tissue death if not treated immediately. The purpose of this study is to predict and explain the impact of
extract on model rats exposed to bleomycin in their lungs as a treatment or anti-fibrinolysis.
This research is an analytical study with a randomized in-vivo experimental design divided into 3 groups of 5 male Wistar rats aged 10 weeks. Negative control group (K) with intratracheal induction of bleomycin alone. The positive group was given intratracheal bleomycin 4 mg/kg/BB on days 0 and 21 and added
induction at 400 mg (P1) on days 15 to 49. The other positive group was given intratracheal bleomycin 4 mg/kg/BB on days 0 and 21 and added
induction at 800 mg (P2) on days 15 to 49. Data were collected according to findings of lung histology analysis of rat samples.
In the interalveolar septum group, there was a difference in Masson's Trichrome staining results in groups K and P1 with p<0.05 (p=0.036). However, there was no difference in histopathological staining results in groups K and P2 (p>0.05).
The induction of bleomycin 4 mg/kg/BB was proven to cause fibrosis in the lungs of rats, and
extract was used as a treatment. Therefore, further research regarding antifibrotic drugs is hoped to reduce fibrotic areas significantly.</abstract><cop>New Zealand</cop><pub>Dove Medical Press Limited</pub><pmid>39345799</pmid><doi>10.2147/JEP.S463899</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-2687-4924</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1179-1454 |
ispartof | Journal of experimental pharmacology, 2024-09, Vol.16, p.311-320 |
issn | 1179-1454 1179-1454 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_71ddcfc62ffe42ba82353a678da9ab4e |
source | Taylor & Francis Open Access; Publicly Available Content (ProQuest); PubMed Central |
subjects | Bleomycin Cancer Care and treatment centella asiatica Chronic diseases Development and progression Fibrosis Lung diseases Original Research pulmonary fibrosis treatment |
title | Bleomycin-Induced Fibrosis and the Effectiveness of Centella Asiatica as a Treatment |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T21%3A12%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bleomycin-Induced%20Fibrosis%20and%20the%20Effectiveness%20of%20Centella%20Asiatica%20as%20a%20Treatment&rft.jtitle=Journal%20of%20experimental%20pharmacology&rft.au=Soeroso,%20Noni%20Novisari&rft.date=2024-09-30&rft.volume=16&rft.spage=311&rft.epage=320&rft.pages=311-320&rft.issn=1179-1454&rft.eissn=1179-1454&rft_id=info:doi/10.2147/JEP.S463899&rft_dat=%3Cgale_doaj_%3EA815289565%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3129-17df2f7216c66cd75c47354365fd4927e2eaa875d515dda35b8e55be8585448a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3111205295&rft_id=info:pmid/39345799&rft_galeid=A815289565&rfr_iscdi=true |